DICE Therapeutics, Inc.
DICE Therapeutics, Inc. (DICE) Stock Overview
Explore DICE Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
2.3B
P/E Ratio
-22.94
EPS (TTM)
$-2.17
ROE
0.56%
DICE Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of DICE Therapeutics, Inc. (DICE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $103.42.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -22.94 and a market capitalization of 2.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.